Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia
article
OA: closed
CC0
⤵ 15 in-corpus citations
AI-generated summary
Mefenamic acid was evaluated for its ability to reduce blood loss in women experiencing heavy menstrual bleeding due to essential menorrhagia.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Prostaglandin synthesis inhibitors decrease menstrual blood loss by 30% to 50% in patients with essential menorrhagia. To obtain insight into their mechanism of action, we measured menstrual blood loss in menorrhagic women, who were receiving mefenamic acid (500 mg, three times daily) (n = 6) or placebo (n = 5) in a double-blind way. In addition we studied the morphology of early menstrual hemostasis. The subjects' uteri were extirpated in the first 24 hours of menstruation, and light and electron microscopy were used to perform morphologic and morphometric studies. In the group treated with mefenamic acid mean menstrual blood loss was decreased by 40%. In uteri of the women treated with mefenamic acid hemostatic plugs were further transformed, and fewer vessels without a plug were observed than in uteri of the group receiving placebo. These data suggest that mefenamic acid may act through an improvement of platelet aggregation and degranulation and through increased vasoconstriction.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (23)
- Efficacy of mefenamic acid in patients with a complaint of menorrhagia. via openalex
- Endometrial prostaglandins and menorrhagia: influence of a prostaglandin synthetase inhibitor in vivo via openalex
- Increased uterine prostaglandin E receptors in menorrhagic women via openalex
- MORPHOLOGY OF HAEMOSTASIS IN MENSTRUAL ENDOMETRIUM via openalex
- Primary and myoma‐associated menorrhagia: role of prostaglandins and effects of ibuprofen via openalex
- Prostaglandins in the human uterus: An interaction between endometrium and myometrium via openalex
- PROSTAGLANDIN SYNTHESIS IN THE ENDOMETRIUM OF WOMEN WITH OVULAR DYSFUNCTIONAL UTERINE BLEEDING via openalex
- REDUCTION OF MENSTRUAL BLOOD-LOSS BY PROSTAGLANDIN-SYNTHETASE INHIBITORS via openalex
- W2029159327 via openalex
- W2062956836 via openalex
- W2120861272 via openalex
- W2146863445 via openalex
- W2161810633 via openalex
- W2436137723 via openalex
- W4299952610 via openalex
- W6602328082 via openalex
- W76153082 via openalex
- W86943527 via openalex
- W156428840 via openalex
- W1678246774 via openalex
- W1964830004 via openalex
- W1987461701 via openalex
- W2000210781 via openalex
Cited by (15)
- Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding 2019
- Medical Management of Heavy Menstrual Bleeding 2015
- Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding 2013
- Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding 2007
- Efficacy of a selective COX-2 inhibitor for controlling irregular uterine bleeding in DMPA users 2006
- Medical management of dysfunctional uterine bleeding 2003
- Medical management of dysfunctional uterine bleeding 1999
- Induction of inducible nitric oxide synthase expression in human secretory endometrium 1998
- Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding 1998
- Medical Management of Menorrhagia in Pre- and Perimenopausal Women 1997
- OFFICE GYNECOLOGY FOR THE PRIMARY CARE PHYSICIAN, PART II 1996
- Treating Menorrhagia in Primary Care: <i>An Overview of Drug Trials and a Survey of Prescribing Practice</i> 1995
- Managing menorrhagia. 1995
- Peri- and Postmenopausal Abnormal Bleeding 1994
- Nonsteroidal antiinflammatory drugs and reproduction 1993
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK